MedAssets is a leading provider of performance enhancement software and services for hospitals and other providers. The Company provides a suite of technology leveraged services that assist providers in managing their medical supply costs and improving their revenue cycle. At the time of its sale, approximately three quarters of the hospitals in the United States and 120,000 other providers were customers of MedAssets and the Company controlled over $50 billion in annual purchasing volume.

United BioSource Corporation is the leading provider of evidence-based commercialization services for the pharmaceutical and life sciences industry. These data driven services help demonstrate the clinical efficacy, safety and cost effectiveness of pharmaceuticals. The scope of the Company’s capabilities includes safety and risk management, health economics and outcomes research. At the time of its sale, UBC was the global leader in post-approval commercialization services.

Summit Behavioral Health is a nationally recognized provider of addiction treatment services. The Company's sole focus is on the provision and management of specialty chemical dependency and addiction disorder services within a flexible and dynamic continuum of care. Summit’s network of facilities provide detoxification services, residential treatment, partial hospitalization, intensive outpatient care and specialized programming.